Glymphatic Function May Predict Seizure Treatment Success

Source: Frontiers in neurology

Summary

Researchers studied 155 patients with drug-resistant focal epilepsy to see if a specific brain imaging method could help predict how well they would respond to a medication called lacosamide (LCM). The patients had undergone a type of brain scan known as diffusion tensor imaging (DTI) before starting LCM therapy and were followed for at least a year to track their seizure activity. The goal was to determine if the DTI-ALPS index, which measures brain waste clearance, could indicate whether patients would benefit from the treatment.

The study found that patients who responded well to lacosamide had a higher DTI-ALPS index compared to those who did not respond. Specifically, responders had a score of 1.4022, while non-responders had a score of 1.1936. Additionally, non-responders had taken more previous medications and showed more frequent abnormal brain activity on tests. This suggests that the ability of the brain to clear waste might be linked to how well patients respond to this medication.

Understanding the DTI-ALPS index's role is important because it could help doctors predict which patients might benefit from lacosamide, potentially leading to better treatment decisions. However, the study has limitations, such as being retrospective and involving a specific group of patients, which means more research is needed to confirm these findings in different populations.

Original source